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Abstract
Background
It has been suggested that Schistosoma infection may be associated with Plasmodium fal-
ciparum infection or related reduction in haemoglobin level, but the nature of this interaction
remains unclear. This systematic review synthesized evidence on the relationship of S. hae-
matobium or S. mansoni infection with the occurrence of P. falciparum malaria, Plasmodium
density and related reduction in haemoglobin level among children in sub-Saharan Africa
(SSA).
Methodology/Principal findings
A systematic review in according with PRISMA guidelines was conducted. All published
articles available in PubMed, Embase, Cochrane library and CINAHL databases before
May 20, 2015 were searched without any limits. Two reviewers independently screened,
reviewed and assessed all the studies. Cochrane Q and Moran’s I2 were used to assess het-
erogeneity and the Egger test was used to examine publication bias. The summary odds
ratio (OR), summary regression co-efficient (β) and 95% confidence intervals (CI) were esti-
mated using a random-effects model. Out of 2,920 citations screened, 12 articles (five
cross-sectional, seven prospective cohort) were eligible to be included in the systematic
review and 11 in the meta-analysis. The 12 studies involved 9,337 children in eight SSA
countries. Eight studies compared the odds of asymptomatic/uncomplicated P. falciparum
infection, two studies compared the incidence of uncomplicated P. falciparum infection, six
studies compared P. falciparum density and four studies compared mean haemoglobin
level between children infected and uninfected with S. haematobium or S. mansoni.
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Summary estimates of the eight studies based on 6,018 children showed a higher odds of
asymptomatic/uncomplicated P. falciparum infection in children infected with S. mansoni or
S. haematobium compared to those uninfected with Schistosoma (summary OR: 1.82; 95%
CI: 1.41, 2.35; I2: 52.3%). The increase in odds of asymptomatic/uncomplicated P. falcipa-
rum infection among children infected with Schistosoma remained significant when sub-
group analysis was conducted for S. haematobium (summary OR: 1.68; 95%CI: 1.18, 2.41;
I2: 53.2%) and S. mansoni (summary OR: 2.15; 95%CI: 1.89, 2.46: I2: 0.0%) infection. How-
ever, the density of P. falciparum infection was lower in children co-infected with S. haema-
tobium compared to those uninfected with Schistosoma (summary-β: -0.14; 95% CI: -0.24,
-0.01; I2: 39.7%). The mean haemoglobin level was higher among children co-infected with
S. haematobium and P. falciparum than those infected with only P. falciparum (summary-
mean haemoglobin difference: 0.49; 95% CI: 0.04, 0.95; I2: 66.4%)
Conclusions/Significance
The current review suggests S. mansoni or S. haematobium co-infection may be associated
with increased prevalence of asymptomatic/uncomplicated P. falciparum infection in chil-
dren, but may protect against high density P. falciparum infection and related reduction in
haemoglobin level.
Author Summary
A clear understanding of the epidemiology of malaria during Schistosoma co-infection
is essential to inform decisions on appropriate control strategies for schistosomiasis
and malaria in SSA. In this systematic review and meta-analysis, we synthesized evi-
dence on the nature of relationship of S. haematobium and S. mansoni infection with
the prevalence/incidence of P. falciparum infection, density of the parasite and related
reduction in haemoglobin level among children in SSA. We searched all published arti-
cles available in PubMed, Embase, Cochrane library and CINAHL databases before
May 20, 2015 without any language restriction. We found five cross-sectional and
seven prospective cohort studies eligible to be included in the systematic review, and 11
of these studies were included in the meta-analysis. A summarized analysis of the study
findings showed that S. haematobium and S. mansoni infection is associated with an
increased odds of asymptomatic/uncomplicated P. falciparum infection. However, den-
sity of P. falciparum infection decreased and haemoglobin level increased during S. hae-
matobium co-infection.
Introduction
Malaria and schistosomiasis are common in tropical and sub-tropical areas, causing high bur-
den of morbidity and mortality, particularly in children [1,2]. In 2015, about 214 million peo-
ple were infected and 438,000 estimated to have died globally due to malaria [1]. Additionally,
more than 261 million people required preventive treatment for schistosomiasis and close to
200,000 are estimated to die due to this disease annually [2]. About 90% of the malaria deaths
and 90% of those who require treatment for schistosomiasis live in sub-Saharan Africa (SSA),
with children being the most affected group [1,2]. Plasmodium falciparum (P. falciparum) is
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responsible for most malaria cases and deaths due to the disease in SSA [3–5]. Likewise, two
schistosome species, Schistosoma mansoni (S. mansoni) and S. haematobium are responsible
for almost all of schistosomiasis cases in SSA [6]. S. mansoni causes intestinal and hepatic
schistosomiasis and S. haematobium causes urogenital schistosomiasis [6]. Both Schistosoma
spp. cause inflammation that leads to anaemia, growth stunting or cognitive impairment [6].
Humans infected with Plasmodium species that cause malaria can manifest a wide range of
symptoms that vary from asymptomatic infection to severe complications resulting in death
[6–8]. Severe malaria complications such as cerebral malaria, respiratory failure, acute renal
failure or severe anaemia usually occur when unimmune individuals get infected with P. falcip-
arum [7]. On the other hand, people living in regions where there is stable malaria transmis-
sion will usually show common symptoms such as fever, chills, fatigue, malaise when infected
with Plasmodium spp. [8,9]. Still some immune individuals infected with Plasmodium may not
develop fever, chills or other acute clinical symptoms of malaria, or may show symptoms inter-
mittently but not severe enough to require attention from a health care provider [8].
Schistosoma co-infection can affect the development of Plasmodium infection related symp-
toms by altering the immune function [10]. Distributions of Plasmodium and Schistosoma spe-
cies overlap in most of SSA, resulting in high rates of co-infection [11]. Based on the
immunological findings in murine models and human subjects, it is hypothesized that there is
a down-regulating effect of Schistosoma on the immune system of individuals, which in turn,
may affect the course of other intracellular infections like Plasmodium [10]. However, research
on the course of P. falciparum infection and related outcomes during Schistosoma co-infection
has generated contradictory findings. While some studies report increased odds of P. falcipa-
rum infections and/or malaria-related complications associated with S. haematobium or S.
mansoni co-infections [12–14], others reported lower incidence and density of P. falciparum
infection in children with S. haematobium infection [15,16]. Some studies reported lack of sta-
tistically significant association between S. mansoni or S. haematobium and the risk of P. falcip-
arum infection [17,18]. The differences in study design, age groups, and outcomes may have
blurred attempts to reach clear conclusions.
In order to reduce adverse impact of schistosomiasis on child health, it is recommended
that children living in endemic regions be treated with praziquantel [19]. However, if co-infec-
tion with schistosomiasis may reduce children’s susceptibility to the more severe form of P. fal-
ciparum malaria, then such treatment might have unwanted consequences. Thus, a clear
understanding of the epidemiology of malaria during Schistosoma co-infection is essential to
inform decisions on appropriate control strategies for schistosomiasis and malaria in SSA.
Two previous reviews examining helminth and malaria co-infection, partially addressed the
issue of Schistosoma and malaria co-infection in the general population based on studies con-
ducted in various regions of the world [20,21]. However, the current systematic review and
meta-analysis was undertaken to quantify the odds of asymptomatic/uncomplicated P. falcipa-
rum infection, parasite density and P. falciparum malaria-related reduction in haemoglobin
level in Schistosoma co-infected children in SSA.
Methods
The protocol for this systematic review and meta-analysis was conducted following the
PRISMA guidelines [22] (S1 Table). It would have been preferable to register this study with
PROSPERO [23, 24], an international registry of systematic reviews, from the onset to mini-
mize the potential for reporting bias. However, we did not decide to seek publication until
after the review had been conducted. The aim of PROPERO is to minimize reporting bias, par-
ticularly if there have been major changes to methods which could potentially introduce biases
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through increased knowledge of potentially eligible studies leading to the narrowing of objec-
tives or the addition of new outcome measures. Fortunately, we did not make changes on the
methods for conducting this review after we had developed the protocol.
Eligibility criteria
All epidemiological studies except case studies which reported prevalence or incidence of P.
falciparum infection and/or Plasmodium density stratified by the presence or absence of S. hae-
matobium or S. mansoni infection among children living in SSA were included. Studies that
reported immunology of P. falciparum malaria and S. haematobium or S. mansoni co-infection
in the general population were also included if they reported the prevalence or incidence of P.
falciparum infection in children separately. Unpublished studies, conference abstracts, proto-
col, gray literature, review protocols, studies that involved only adults or pregnant women, ani-
mal or in vitro studies, and studies conducted outside of SSA were excluded after screening the
titles and abstracts. Studies were additionally excluded after full text review when children
infected with Schistosoma were co-infected with soil transmitted helminths or if they lacked
epidemiologic data on P. falciparum and Schistosoma co-infection.
Outcome measures
The primary outcomes were prevalence/incidence of P. falciparum infection. Asymptomatic/
uncomplicated P. falciparum malaria was defined as microscopic confirmation of the Plasmo-
dium parasite in blood without clinical evidence (signs or symptoms) of severe malaria [25].
Seven studies included in this review did not clearly differentiate cases based on the clinical
stages of malaria as asymptomatic and/or symptomatic. Although three studies indicated
malaria cases as asymptomatic and symptomatic, results on P. falciparum and Schistosoma co-
infection was not done on basis of the clinical stages of malaria. Hence, this review did not
make any distinction between asymptomatic and uncomplicated P. falciparum malaria while
estimating the nature of association of Schistosoma co-infection with P. falciparum malaria.
Secondary outcomes included asexual stage (ring forms) Plasmodium density per microliter
of blood, haemoglobin levels per deciliter of blood and anaemia. Anaemia was defined as hae-
moglobin level below the cut-off values defined by WHO: 11.0 g/dl for children 6–59 months;
11.5 g/dl for children 5–11 years; 12.0 g/dl for children 12–14 years [26]. S. haematobium and
S. mansoni infections were confirmed in all studies by urine filtration and Kato Katz tech-
niques, respectively.
Search methods for identification of studies
Two authors (AD and DD) independently conducted a search in Pubmed, Embase, Cochrane
Library, CINAHL databases using keywords: malaria OR Plasmodium OR “Plasmodium falcip-
arum” OR “Plasmodium vivax” in combination with helminth OR Schistosoma OR “Schisto-
soma mansoni” OR “Schistosoma haematobium” (S2 Table) for articles published before May
20, 2015. The search was limited to humans, but no limits were made on language. References
of some related reviews [10,11,20,21] and African Online Journals database were also searched
for relevant studies. Following exclusion of duplicates; abstracts and titles of 2,149 papers were
screened for eligibility criteria and 45 were chosen for full text evaluation. Any discrepancies
in the choice of articles being included in the review were resolved by third reviewer adjudica-
tion. However, there was a very low degree of discrepancy between the two authors in the
choice of articles for the review.
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Data collection
Information about the author, study area, study design, sample size, age range, Schistosoma
species investigated, prevalence of P. falciparum and Schistosoma co-infection, diagnosis tech-
niques and the main findings on prevalence/incidence and density of P. falciparum infection
and mean haemoglobin level/ prevalence of anaemia were abstracted and entered into an excel
sheet by two authors independently. Any discrepancies were resolved by consensus between
the two authors. There was a very low degree of discrepancy between the two authors data that
were extracted from the articles.
Quality and bias assessment
Quality and risk of bias of the studies was evaluated using the effective public health practice
project [27]. The quality of the studies was assessed on the basis of selection of the study partic-
ipants, study design, confounder, blinding, data collection methods and withdrawals and
drop-outs comparability.
Study synthesis
Heterogeneity was assessed using Cochrane Q (Chi-square) and Moran’s I2 (Inconsistency)
using STATA software (Version 11, Texas, USA) [28]. Publication bias was evaluated using a
funnel plot and statistical significance was assessed by the Egger test (bias if p<0.1) [29]. Sub-
group analyses were conducted for S. mansoni and S. haematobium. Odds ratio, relative risk,
regression coefficients, mean differences along with the 95% confidence intervals were used as
effect measures. When studies did not report 95% CI for mean differences in Plasmodium den-
sity or haemoglobin level, we estimated it using p-values as suggested by Altman and Bland
[30]. The 95% CI for mean difference in haemoglobin level between children co-infected with
S. haematobium and P. falciparum and those infected with only P. falciparum for the studies by
Deribew et al. [31] and Ateba-Ngoa et al. [32] was estimated using the mean and standard
deviations values. The mean and standard deviation of haemoglobin levels for Ateba-Ngoa
et al. [32] was estimated from the median and interquartile range based on the formula sug-
gested by Wan et al. [33]. A random effects model was used to estimate the summary Mantel-
Haenszel odds ratio of P. falciparum infection, among children infected with Schistosoma and
those uninfected with Schistosoma. A random effects model was also used to estimate the sum-
mary regression coefficients and mean differences of P. falciparum density among children
infected with S. haematobium and those uninfected with Schistosoma.
Results
Search results and study characteristics
A total of 2,920 citations were identified from PubMed (n = 999), Embase (n = 1,847),
Cochrane library (n = 50) and CINAHL (n = 24), of which 771 articles were found to be dupli-
cates. All relevant articles identified from reviews on malaria and helminth co-infection
[10,11,20,21] and African Journal database were similar with the articles found from the four
databases. Of the 2,149 articles screened; 2104 articles were excluded after reading the titles
and abstracts. Of the 45 full-text articles reviewed, 33 were excluded. A total of 12 articles were
considered for the systematic review, of which 11 were included in the meta-analysis (Fig 1).
The characteristics of the 12 studies with 9,337 subjects included in this review are summa-
rized in Table 1. Five studies were cross-sectional and seven were prospective cohorts. Nine
studied S. haematobium and P. falciparum co-infection, and three studied S. mansoni and P.
falciparum co-infection. Eight studies compared the odds of asymptomatic/uncomplicated P.
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Fig 1. PRISMA diagram. Flow chart for study selection. Hb: Haemoglobin; SSA: sub-Saharan Africa; STH: Soil-transmitted helminths
doi:10.1371/journal.pntd.0005193.g001
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Table 1. Characteristics of the included studies.
Reference Study area
(years of the
survey)
Sample size
(Age range)
Study
Design
Schistosoma
species
Outcomes
Reported
Prevalence of
‘Sh’ or ‘Sm’ &
malaria co-
infection
The magnitude of
outcomes in those co-
infected with ‘Sh’ or ‘Sm’
&Pf compared to those
with only Pf
Diagnostic Techniques
Ateba-Ngoa
et al. 2015
Gabon
(2011)
125 (6–16
years)
CS Sh 1. Pf
prevalence
2. Hb level
26% 1. Similar
2. Higher, mean Hb
difference:0.7; 95% CI:
0.21, 1.19
Malaria: PCR. Sh: Urine
filtration, 3 different day
samples. Stools not checked
Briand et al.
2005
Senegal
(2001 & 2002
523 (3–15
years)
PC Sh Pf density Not given Lower in children with light
intensity ‘Sh’ compared to
children without
Schistosoma (β: -0.34, 95%
CI: −0.85, −0.10)
Malaria: microscope. Sh: Urine
filtration, only1 sample. Other
helminth: Kato Katz. Adjusted
for age, sex, season and level of
exposure
Courtin et al.
2011
Senegal
(2003)
234 (6–16
years)
PC Sh 1. Pf
prevalence
2. Pf density
34% 1. Similar, OR: 1.62; 95%
CI: 0.94, 2.80
2. Similar
Malaria: microscope. Sh: Urine
filtration,1 sample. Stools not
checked
Deribew et al.
2013
Ethiopia
(2008)
387 (6–23
month)
CS Sh 1. Pf
prevalence
2. Anaemia
prevalence
3. Mean Hb
2.84% 1. Higher, OR: 2.8; 95% CI:
1.21, 6.5
2. Higher, OR: 10.12; 95%
CI: 1.47, 69.94
3. Similar,
Malaria: microscope. Sh: Urine
filtration, 1 sample. Stools not
checked
Doumbo
et al.2014
Mali (2011 &
2012)
616 (3 month
to 25 Years)
PC Sh 1. Pf
prevalence
2. Pf risk
(hazard
ratio)
3. Pf density
8.5% 1. Higher, OR: 3.23; 95%
CI: 1.76, 5.90
2. Similar
3. Heavy Sh negatively
associated with Pf density
but light Sh did not
associate with Pf density
Malaria: microscopy & PCR. Sh:
Urine filtration. Stools, 2 sample
Florey et al.
2012
Kenya (2005) 223 (8 to 17
years)
CS Sh Pf
prevalence
31.8% Higher, adjusted OR: 1.79;
95% CI: 1.32, 2.44
Malaria: PCR. Sh: Urine
filtration, 2 samples on different
day. Stool not checked.
Adjusted for water contact, night
activity, bed net use, distance
from water
Kabatereine
et al. 2011
Uganda
(2009 &
2010)
5000 (Mean
age = 12.5
years)
CS Sm Pf
prevalence
23.5% Higher, OR: 2.16; 95% CI:
1.89, 2.47
Malaria: microscope. Sm: Kato
Katz
Lyke et al.
2005
Mali (2002 &
2003)
654 (4–14
years)
PC Sh 1. Pf
incidence
2. Pf density
3. Hb level
1. Lower in children ages 4
to 8
2. Lower in children ages 4
to 8
3. Similar
Malaria: microscope. Sh: Urine
filtration (Sh), 2 to 3 samples.
Other helminths: Kato Katz
Mazigo et al.
2010
Tanzania
(2009)
400 (8–16
years)
CS Sm Pf
prevalence
6% Higher, OR: 2.1; 95% CI:
1.03, 4.26
Malaria: microscopy. Sm: Kato
Katz
Lemaitre
et al. 2014
Senegal
(2001 to
2003)
178 (5–13
years)
PC Sh Pf density lower in children with light
intensity ‘Sh’ compared to
children without
Schistosoma (β−0.28; 95%
CI: -0.52, -0.04)
Malaria: microscopy. Sm: Kato
Katz. Sh: Urine filtration.
Adjusted for Sex, age, village,
season
Sangweme
et al. 2010
Zimbabwe
(2004 &
22005)
485 (6–17
years)
PC Sh 1. Pf
prevalence
2. Pf density
3. mean Hb
4.Anaemia
prevalence
18.8% 1. Similar
2. Lower but not significant,
Sexual stage ‘Pf’ density
was higher in children
infected than uninfected
with ‘Sh’
3. Similar
4. Similar
Malaria: microscopy. Sh: Urine
filtration, 3 samples on different
day. Other helminths: Kato Katz,
3 sample on different day. Only
few cases were infected with Sm
Sokhna et al.
2004
Senegal
(1998)
512 (6–15
years)
PC Sm Pf incidence 13.3% Higher in children with
heavy Sm egg load
compared to those without
helminth (RR: 2.24, 95% CI:
1.20, 4.20)
Malaria: microscope. Sh: Urine
filtration. Other helminth: Kato
Katz
CS: Cross-sectional; CI: Confidence interval; Hb: Haemoglobin; OR: Odds ratio; Pf: Plasmodium falciparum; RR: Relative risk; Sh: Schistosoma
haematobium; Sm: Schistosoma manosni; STH: Soil-transmitted helminths; PC: Prospective cohort; PCR: polymerase chain reaction
doi:10.1371/journal.pntd.0005193.t001
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falciparum infection and six studies compared P. falciparum density between children infected
and uninfected with Schistosoma. Four studies compared mean haemoglobin level/prevalence
of anaemia between children co-infected with P. falciparum and Schistosoma and those
infected with only P. falciparum. Two studies reported uncomplicated P. falciparum infection,
three studies reported both asymptomatic and uncomplicated P. falciparum infection, but
seven studies did not clearly differentiate cases based on the clinical stages of malaria as asymp-
tomatic and/or uncomplicated.
Longitudinal studies by Sangweme et al. [34], Courtin et al. [35] and Doumbo et al. [36] did
not report incidence, hence the prevalence data reported in these studies during the baseline
surveys were used when estimating the summary-odds of P. falciparum infection in children
infected and uninfected with S. haematobium. However, Sokhna et al. [37] reported incidence
of P. falciparum infection in S. mansoni infected children, the study was thus excluded from
the meta-analysis.
Schistosoma haematobium and Plasmodium falciparum infection
Six studies examined the nature of the relationship of S. haematobium infection with the odds
of asymptomatic/uncomplicated P. falciparum infection (Fig 2). A cross-sectional study in
Ethiopia [31] and a prospective cohort study in Mali [36] showed increased odds of asymp-
tomatic/uncomplicated P. falciparum infection among children infected with S. haematobium
compared to children uninfected with S. haematobium. A cross-sectional study in Kenya also
showed higher odds of asymptomatic/uncomplicated P. falciparum infection in children
infected with S. haematobium compared to those uninfected with S. haematobium after adjust-
ing for the effects of water contact, night activity, bednet use and distance from water (adjusted
Fig 2. Forest plot showing the difference in the prevalence of asymptomatic/uncomplicated P. falciparum malaria between children infected with
S. haematobium or S. mansoni and those not infected with Schistosoma in SSA.
doi:10.1371/journal.pntd.0005193.g002
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OR: 1.79; 95% CI: 1.32, 2.44) [38]. Although the difference was not statistically significant,
prospective cohort studies in Zimbabwe [34] and Senegal [35] showed higher odds of asymp-
tomatic/uncomplicated P. falciparum infection in children infected with S. haematobium com-
pared to those who were not infected with S. haematobium. However, a cross-sectional study
in Gabon showed similar odds of asymptomatic/uncomplicated P. falciparum infection in chil-
dren infected with S. haematobium and those uninfected with S. haematobium [32]. The over-
all estimates based on six studies showed higher odds of asymptomatic/uncomplicated P.
falciparum infection in children infected with S. haematobium than those uninfected with S.
haematobium (summary OR: 1.68; 95%CI: 1.18, 2.41; I2: 53.2%) [31,32, 34–36, 38]. However,
longitudinal studies in Mali showed similar risk of uncomplicated P. falciparum infection in
children infected and uninfected with S. haematobium [16,36]. Age-stratified analysis of the
data in the study by Lyke et al. [16], showed association of S. haematobium infection with
fewer episodes of P. falciparum infection in children of ages 4 to 8 years, but the association
was no longer present in children aged 9 to 14 years. Additionally, the study by Doumbo et al.
[36] showed association of baseline co-infection with S. haematobium and P. falciparum with
reduced risk of febrile P. falciparum infection.
Schistosoma mansoni and Plasmodium falciparum infection
A cross-sectional study of 5,000 children in Uganda showed higher odds of uncomplicated
P. falciparum infection among children infected than those uninfected with S. mansoni [39].
Another cross-sectional study in Tanzania documented increased odds of asymptomatic/
uncomplicated P. falciparum malaria among children infected with S. mansoni than children
without S. mansoni infection [40]. A summary analysis based on the two studies [39,40]
showed higher odds of asymptomatic/uncomplicated P. falciparum infection among children
infected than those not infected with S. mansoni (summary OR: 2.15; 95%CI: 1.89, 2.46; I2:
0.0%). Similarly, a prospective cohort study in Senegal showed increased risk of uncomplicated
P. falciparum infection in children with S. mansoni egg load >1000 eggs/gram as compared to
those uninfected with Schistosoma (RR: 2.24, 95% CI: 1.20, 4.20) [37]. However, this associa-
tion was not seen in children with moderate intensity S. mansoni egg load (100 to 399 eggs/
gram). The overall estimates based on eight studies [31, 32, 34–36, 38–40] showed higher odds
of asymptomatic/uncomplicated P. falciparum infection in children infected with S. mansoni
or S. haematobium as compared to those uninfected with Schistosoma (summary OR: 1.82;
95%CI: 1.41, 2.35; I2: 52.3%). There was no publication bias detected in the meta-analysis
(Egger test = -1.89; p = 0.11), which included eight studies (S1 Fig). Subgroup analysis showed
that the increase in odds of asymptomatic/uncomplicated P. falciparum infection among chil-
dren infected with Schistosoma was significant for studies which used microscopy for the diag-
nosis of Plasmodium infection (summary OR: 1.91; 95%CI: 1.52, 2.40; I2: 31.8%) and those
conducted in East African region (summary OR: 1.91; 95%CI: 1.51, 2.42; I2: 31.7%). However,
significant association was not seen between asymptomatic/uncomplicated P. falciparum
infection and Schistosoma among studies which used polymerase chain reaction (PCR) for the
diagnosis of Plasmodium infection and those conducted in the West African region (S2 Fig).
Schistosoma infection and Plasmodium falciparum density
Out of the 12 studies included in this review, six prospective cohort studies examined the effect
of S. haematobium infection on the density of P. falciparum infection. Among these six studies,
two reported lower P. falciparum density among children with low intensity of S. haematobium
infection (<10 eggs/10ml urine) as compared to those uninfected with Schistosoma [15,41]. A
study in Mali showed lower P. falciparum density in children with heavy intensity S.
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haematobium infection compared to those uninfected with Schistosoma [36]. A summary anal-
ysis based on the three studies showed significantly lower P. falciparum density in children
infected with S. haematobium as compared to those uninfected with Schistosoma (summary
β = -0.14; 95% CI = -0.24, -0.01; I2 = 39.7%) [15, 36, 41]; the difference was greater in children
with low intensity S. haematobium infection (summary β = -0.30; 95% CI = -0.47, -0.12; I2 =
4.4%) (Fig 3). A study in Mali also showed significantly lower P. falciparum density among
children aged 4 to 8 years with low-intensity S. haematobium infection compared to those
uninfected with S. haematobium, however this difference in P. falciparum density was not
Fig 3. Effect of S. haematobium infection on P. falciparum density in children in SSA.
doi:10.1371/journal.pntd.0005193.g003
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significant (p = 0.19) when data were analyzed without stratifying by age and intensity of S.
haematobium infection (5521 vs.6761) [16]. Although the difference was not statistically signif-
icant, the density of P. falciparum infection tended to be lower in children infected with S. hae-
matobium (mean = 1764) compared to those uninfected with S. haematobium (mean = 2509),
irrespective of the intensity of S. haematobium infection (p = 0.4) [34]. In contrast, a study in
Senegal showed lack of significant difference in mean P. falciparum densities in infected chil-
dren (mean = 626) compared to those uninfected (mean = 444) with S. haematobium but data
were not stratified based on intensity of S. haematobium infection (p = 0.56) [35]. Based on a
summary analysis of the data in the three studies [16,34,35], P. falciparum density tended to be
lower in children infected with S. haematobium than those uninfected with the parasite (mean
difference = -924.2, 95% CI = -2151.8, 303.4; I2 = 0.0). The differences in some of the afore-
mentioned studies in mean P. falciparum densities among children with moderate or heavy
(>10 eggs/10ml urine) intensity of S. haematobium infection compared to those not infected
with the parasite were not significant [15,16,41]. The significant protective effects were largely
seen in children with light intensity of S. haematobium infection.
Co-infection with Schistosoma and Plasmodium falciparum and
haemoglobin level
Out of 12 studies included in this review, four studies reported findings on mean haemoglo-
bin level among children co-infected with P. falciparum and S. haematobium and those
infected with only P. falciparum. A study in Gabon reported higher haemoglobin level
among children co-infected with S. haematobium and P. falciparum than those infected
with only P. falciparum (mean haemoglobin difference = 0.7; 95% CI = 0.21, 1.19) [32].
However, three studies in Mali, Ethiopia and Zimbabwe showed similar mean haemoglobin
levels in children co-infected with S. haematobium and P. falciparum and those infected
with only P. falciparum [16,31,34]. A summary estimate based on three studies [31, 32,34]
showed higher mean haemoglobin level in children co-infected with S. haematobium and P.
Fig 4. Mean haemoglobin differences between children co-infected with S. haematobium and asymptomatic/uncomplicated P. falciparum and
those infected with only P. falciparum.
doi:10.1371/journal.pntd.0005193.g004
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falciparum than those infected with only P. falciparum (summary mean haemgolobin level
difference = 0.49; 95% CI: 0.04, 0.95; I2: 66.4%) (Fig 4). Among the four studies, two studies
reported the odds of anaemia among children co-infected with P. falciparum and S. haema-
tobium and those infected with only P. falciparum. The study in Ethiopia reported increased
odds of anaemia [31], but the study in Zimbabwe [34] reported similar odds of anaemia in
children co-infected with S. haematobium and P. falciparum as compared to those infected
with only P. falciparum. All the four studies reported similar mean haemoglobin level in
children infected with S. haematobium, and those uninfected with S. haematobium and P.
falciparum [16,31,32,34].
Quality of the studies
Table 2 summarizes the quality of the studies included in this review in terms of selection bias,
study design, confounders, blinding, data collection methods, withdrawals and dropouts. The
majority of the studies showed strong quality in data collection methods. The quality of most
studies included in this review was moderate in terms of design (prospective cohort), control
of selection bias and blinding. Overall rating based on the six criteria showed that two studies
were strong quality, six studies were of moderate quality and four studies were of weak quality.
None of the studies were excluded from the review because of quality issues.
Discussion
In the present systematic review of 12 studies based on 9,337 children in eight SSA countries, a
meta-analysis of 11 studies confirmed increased odds of asymptomatic/uncomplicated P. fal-
ciparum infection among children infected with S. haematobium or S. mansoni as compared to
those uninfected with Schistosoma in SSA. However, lower P. falciparum density was associ-
ated with S. haematobium co-infection, particularly when the intensity of S. haematobium
infection was low. The finding of a higher prevalence of asymptomatic/uncomplicated P. fal-
ciparum infection among children infected with Schistosoma could be due to the occurrence
Table 2. Assessment of the quality of the studies included in the review based on Effective Public Health Practice Project: Quality assessment
tool for quantitative studies.
No. Author, Year Selection
Bias
Study
Design
Confounders Blinding Data Collection
Methods
Withdrawals and
Drop-Outs
Final
Rating
1 Ateba-Ngoaet al.,
2015
2 3 3 2 1 NA 2
2 Briand et al. 2005 2 2 1 2 1 1 2
3 Courtin et al. 2011 2 2 3 2 1 3 3
4 Deribew et al. 2013 2 3 3 2 1 NA 3
5 Doumbo et al. 2014 1 2 1 2 1 1 1
6 Florey et al. 2012 3 3 2 2 1 NA 3
7 Kabatereineet al.
2011
2 3 2 2 2 NA 2
8 Lyke et al. 2005 3 2 1 2 1 1 2
9 Mazigo et al. 2010 2 3 3 2 1 NA 3
10 Lemaitre et al. 2014 2 2 1 2 1 3 2
11 Sangweme et al.
2010
1 2 2 2 1 3 2
12 Sokhna et al. 2004 2 2 2 2 1 1 1
1 = strong 2 = moderate 3 = weak NA = not applicable
doi:10.1371/journal.pntd.0005193.t002
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of common social or environmental factors increasing the susceptibility of individuals to
infection with both parasite groups [11]. The increased prevalence of asymptomatic/uncom-
plicated P. falciparum infection may result from both increased infection duration and/or
increased incidence of the parasite. Increased incidence and infection duration could result
from immune responses against chronic Schistosoma infection down regulating the effective
response against P. falciparum infection [10]. Hence, P. falciparum parasites could persist for
longer duration in children with chronic Schistosoma infection. P. falciparum sporozoites could
have increased survival in liver, which is immunologically affected by S mansoni egg granulomas
[10]. Children co-infected with S. mansoni may thus be more susceptible to P. falciparum in-
fection. Another hypothesis is that anaemia associated with Schistosoma infection may cause
hyperventilation of carbon dioxide and increased lactates, making the infected individuals more
attractive for mosquitoes and thus increasing their risk for Plasmodium infection [42].
However, the finding of lower P. falciparum density among children with low intensity S.
haematobium infection could be due to an imbalance in Th1/Th2 immune response, which
might modulate the proportion of cytophylic antibodies that control Plasmodium parasitemia
[10]. Low intensity S. haematobium may thus promote an effective Th1 immune response that
will also have a protective effect against P. falciparum. In contrast, increased intensity S. hae-
matobium infections may enhance a Th2 immune response that alter the protective Th1
response.
Studies included in this review showed varying effects of Schistosoma infection on the risk
of acquiring P. falciparum infection [16, 36, 37]. This could be due to varying relationships of
Schistosoma and P. falciparum infection based on the age of the host [16] and intensity of Schis-
tosoma infection [16, 37] or due to small number of cases with insufficient power to detect sta-
tistically significant differences [36]. Indeed, the studies included in this review showed similar
risk of acquiring uncomplicated P. falciparum infection in children infected and uninfected
with S. haematobium when data were analyzed without stratifying by study participants’ ages
or Schistosoma infection intensity [16, 36, 37]. However, the risk of acquiring uncomplicated
P. falciparum infection and the density of parasitemia varied with the S. haematobium or S.
mansoni infection status when data were analyzed stratified by age of the study participants or
intensity of Schistosoma infection. For example, the risk of P. falciparum infection was higher
among children with S. mansoni egg load>1000 eggs/per gram compared to children without
S. mansoni, but this association was not seen when the analysis was restricted to children with
moderate intensity S. mansoni egg load (100 to 399 eggs/per gram) [37]. Lyke et al. [16]
showed delayed time to first clinical episode of malaria, fewer episodes, and lower levels of
parasitemia in S. haematobium infected children aged 4 to 8 years compared to children unin-
fected with S. haematobium; this protective effect was not seen in children aged 9 to 14 years.
Importantly, the decrease in incidence of P. falciparum infection and density of the parasite as
well as the increased time to first clinical P. falciparum infection was more pronounced in chil-
dren excreting low numbers of S. haematobium eggs than those excreting heavy S. haemato-
bium eggs [16]. Doumbo et al [36] found a lower risk of asymptomatic/uncomplicated P.
falciparum infection in children who were co-infected with S. haematobium and P. falciparum
at baseline, but S. haematobium mono-infection at baseline (seen only in 23 children) was not
significantly associated with protection from P. falciparum infection.
The summary estimates of the three studies included in this review showed a higher mean
haemoglobin level in children co-infected with S. haematobium and P. falciparum than in
those infected with only P. falciparum [31, 32, 34]. This result could reflect the immunological
effects of Plasmodium infection on erythropoiesis and haemoglobin levels through interferon
(IFN)-γ and tumor necrosis factor (TNF)-ᾳ activation [43]. Chronic Schistosoma infection
stimulates anti-inflammatory cytokines interleukin (IL)-10 and Transforming growth factor
Plasmodium falciparum Infection Status among Children with Schistosoma
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005193 December 7, 2016 13 / 18
(TGF)-β, which down-regulate (IFN)-γ and TNF-ᾳ [10]. Hence, Schistosoma infection may
attenuate the haemoglobin reduction due to immunological effects of Plasmodium. However,
in some studies included in this review, the findings of a lack of significant difference in hae-
moglobin levels between children co-infected with S. haematobium and P. falciparum and
those infected with only P. falciparum could reflect different clinical stages of Plasmodium
infection and/or low intensity Schistosoma infections. While chronic low Plasmodium parasi-
taemia affect haemoglobin through dyserythropoiesis, the effect of acute initial Plasmodium
infection on haemoglobin is mainly the result of hemolysis [11]. Moreover, the effect of Schis-
tosoma infection on the immunological modulation of Plasmodium related dyserythropoiesis
could be low when the intensity of infection is light.
Public health implications
The findings of this review suggest that treatment of children in SSA for schistosomiasis may
reduce the risk of asymptomatic/uncomplicated P. falciparum infection. Hartgers and Yazdan-
bakhsh, [10] suggested that praziquantel treatment may boost antimalarial immune response
by reducing the down-regulating effect of Schistosoma [10]. However, the reasons why studies
reported lower Plasmodium density among children with light [15, 16, 41], heavy [36] or any
[34] intensity S. haematobium infection remains unclear. In addition, the impact of Schisto-
soma infection on risk of acquiring P. falciparum infection and severity of the disease is poorly
understood. Thus, the question of whether the present mass treatment of children living in
SSA against schistosomiasis could have some detrimental impact through more severe P. fal-
ciparum infection cannot be definitely answered based on this review. Mass treatment pro-
grams generally focus only on the control of schistosomiasis among school-age children in
SSA. Since malaria and schistosomiasis frequently co-exist in school-age children and schisto-
somiasis appears to be associated with increased odds of P. falciparum infection, collaboration
among control programs for both infections and other services for young children might be
advantageous.
Strengths and limitations
This is the first meta-analysis to study association of P. falciparum and Schistosoma co-infec-
tion conducted and reported according to the PRISMA guidelines [22]. Studies included in the
meta-analysis did not show publication bias. The summary estimates of P. falciparum density
in children infected with S. haematobium compared with those uninfected with Schistosoma
were adjusted estimates [15, 36, 41]. However, the present summary results in the meta-analy-
ses of odds of asymptomatic/uncomplicated P. falciparum infection in children infected with
Schistosoma were based on crude estimates of individual studies. Only one study provided
adjusted estimates of the effect size [38]. Hence, the current summary estimates might have
been affected by confounders that can influence the nature of relationship of Schistosoma and
P. falciparum in the original studies. In addition, there was a moderate level of bias in selecting
the study participants within the studies included in this review. This might have resulted in
overestimation of the relationship between Schistosoma and asymptomatic/uncomplicated P.
falciparum malaria in the current review. Intervention measures taken against Schistosoma or
malaria in different regions before the studies could have also altered the nature of relationship
between P. falciparum and Schistosoma. This could also have introduced bias into the review.
Furthermore, there was a moderate level of heterogeneity among the studies examining associ-
ation of P. falciparum and Schistosoma co-infection (Moran’s I2: 52.3.1%, Cochran’s Q: 14.66,
p = 0.041). However, after removing one study [32], the heterogeneity decreased (Moran’s I2:
31.1%, Cochran’s Q: 8.66 p = 0.191)] and subgroup analysis further minimized the risk of
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heterogeneity among studies evaluating the effect of S. mansoni infection on the odds of P. fal-
ciparum infection (I2: 0.0%).
Limitations of the original studies related to the diagnosis of Plasmodium and Schistosoma
infection could also affect the present results [44,45]. In addition, some studies which exam-
ined S. haematobium and P. falciparum co-infection did not examine the study participants for
infection with soil-transmitted helminths. Therefore, children without S. haematobium infec-
tion may have had other helminth infections that could have further confounded the results
[46,47]. Moreover, some studies included in this review did not follow WHO criteria to deter-
mine classes of intensity of Schistosoma infection. This made it difficult to clearly evaluate the
potential effect of classes of intensity of Schistosoma infection on the current result. Finally, the
lack of sufficient data precluded performing a meta-analysis to estimate the effect of Schisto-
soma co-infection on the risk of acquiring P. falciparum infection and related anaemia. We did
not find any studies which examined the relationship between Schistosoma and P. vivax infec-
tion or severe malaria that were eligible in the present review.
Conclusions
The present review suggests that S. mansoni or S. haematobium co-infection may increase sus-
ceptibility of children for asymptomatic/uncomplicated P. falciparum infection. However, S.
haematobium co-infection may protect against high P. falciparum density and related reduc-
tion in haemoglobin level. Findings on the effect of Schistosoma infection against the risk of P.
falciparum infection are heterogeneous.
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